Oracle_header

Cloud, debt and AI promises: the Oracle checklist before earnings

Key takeaways

  • Oracle reports Q2 fiscal 2026 earnings on 10 December 2025, with investors focused on AI cloud growth and backlog.

  • Q1 results showed 12% revenue growth and a 359% jump in cloud backlog, but also heavy spending and rising debt.

  • Long-term investors can watch cloud growth, backlog conversion and balance sheet discipline instead of trying to guess the headline number.


Oracle walks into this week’s Q2 fiscal 2026 earnings with one of the biggest AI backlogs in the market and a more cautious shareholder base than a few months ago. The company reports after the US close on 10 December 2025, with the call set to focus less on last quarter’s profit and more on how fast Oracle can turn promised AI workloads into real cash.

For long-term investors, the question is not whether Oracle beats consensus by a cent. It is whether the numbers and guidance still support the story of a legacy software giant turning itself into a durable AI and cloud infrastructure platform.

The story since last quarter: from AI euphoria to hangover

Oracle’s Q1 fiscal 2026 results in September delivered a rare mix of solid growth and jaw dropping backlog numbers. Revenue rose 12% year on year to 14.9 billion USD, with total cloud revenue up 28% to 7.2 billion USD and cloud infrastructure up 55%.

The real headline, though, was remaining performance obligations (RPO), a measure of contracted future revenue. RPO jumped 359% year on year to 455 billion USD, helped by several multi-billion AI cloud deals, widely reported to include a huge contract with OpenAI.

Initially, the market loved it. Oracle’s share price spiked on the Q1 release as investors tried to price in years of AI demand landing on Oracle’s data centres. Then the mood flipped. Once it became clear how much of that backlog came from a single customer, and how much capital spending would be needed to serve it, the stock dropped about a third from its high.

Since then, scepticism has centred on two themes. First, whether OpenAI and other AI partners can actually deliver the revenue implied by those contracts. Second, how far Oracle’s leverage and interest costs can rise before they start to constrain flexibility for dividends, buybacks or further expansion.

Where the growth is really coming from

Behind the noise, Oracle’s business mix is changing quite fast.

The growth engine today is Oracle Cloud Infrastructure (OCI), the part of the group that sells raw computing power, storage and networking for AI training, inference and traditional workloads. OCI revenue grew 55% in Q1, and management has guided for 77% growth this fiscal year to about 18 billion USD, with even faster growth pencilled in for the following years based largely on already signed contracts.

On top of that sit Oracle’s cloud applications. Fusion and NetSuite enterprise resource planning software, along with healthcare systems from the Cerner acquisition, continue to grow at healthy double-digit rates. These businesses look less exciting than AI data centres, but they add subscription style, recurring revenue that can smooth the cycle if AI spending ever takes a pause.

Legacy software and on premises licences now play a different role. Growth here is slow or flat, but these products still generate sizeable cash that can help fund the build out of new cloud regions and AI capacity. The risk is that higher depreciation and interest costs from that build out squeeze margins before the newer businesses fully scale.

In short, the numbers this week will tell investors how smoothly Oracle is shifting from a high margin, slower growth licence model to a heavier, more capital intensive AI infrastructure model.

What the market is expecting into this print

Wall Street is looking for another strong quarter on the surface. Bloomberg consensus points to Q2 fiscal 2026 revenue around 16.2 billion USD, up roughly 15% year on year, and adjusted earnings per share of about 1.64 USD, growing in the low teens.

That sits above Oracle’s own guidance from September, which implied more modest earnings per share growth for Q2, and leaves some room for disappointment if margins come under pressure from data centre build outs.

Investors are likely to focus on three lines more than the headline earnings per share figure:

1. 
Cloud infrastructure growth: does OCI growth stay near or above the 50% mark needed to support management’s full year targets?

2. 
RPO and bookings quality: does total backlog grow again, and do management comments suggest a broader customer base beyond a few mega AI deals?

3. 
Margins and capital expenditure: how quickly are depreciation and interest costs rising, and what does that imply for free cash flow in the next couple of years?

With the share price still recovering from its autumn correction, “good enough” numbers may not move the needle unless they come with reassuring messages on balance sheet discipline and AI customer diversification.

Risks to watch on the night

The first risk is execution. Oracle must actually build and power the data centres that sit behind its huge backlog. Delays, cost overruns or supply constraints could slow the pace at which RPO turns into recognised revenue.

The second risk is financial. Net debt and interest costs have risen as Oracle funds capacity for AI workloads, while free cash flow has dipped into negative territory in recent quarters. If that continues, rating agencies and income focused shareholders may get more nervous.

The third risk is customer concentration and AI hype. A large portion of Oracle’s backlog appears linked to a small group of AI leaders, including OpenAI, which itself faces rising competition from rivals and questions over long term monetisation. Any sign of contract resizing, delay or renegotiation would be taken seriously by the market.

Early warning signs to scan for in the release and call include slower OCI growth, a flattening of RPO, more cautious comments on capital expenditure, or vague language around major AI customers.

Investor playbook: how to read the earnings

  • Think in trends, not quarters. Track whether cloud growth, RPO and margins broadly match Oracle’s multi-year guidance, rather than fixating on a single print.
  • Separate “backlog story” from “cash story”. A bigger RPO only helps if it turns into revenue and, eventually, free cash flow that can service debt and reward shareholders.
  • Watch balance sheet flexibility. Follow net debt, interest costs and capital expenditure over several quarters to see whether Oracle can grow aggressively without boxing itself in financially.
  • Use scenarios. Consider how your long-term view would change if OCI growth stays above 50%, drops to 30%, or accelerates further, instead of anchoring on a single forecast.

Big AI promises need boring delivery

Oracle’s Q2 report is unlikely to settle every debate about its AI future in one evening. It can, however, show whether the company is quietly doing the hard, boring work of turning a spectacular backlog and ambitious guidance into steady, repeatable progress.

Since September, the market has given Oracle a taste of both extremes: euphoria when the AI contracts appeared, and anxiety when investors dug into who signed them and what they would cost to serve. This week’s numbers and commentary will sit somewhere in between those two moods.

For investors, the edge is less in guessing whether earnings per share land at 1.63 USD or 1.65 USD, and more in watching whether each quarter nudges Oracle further along the path from hopeful AI landlord to disciplined, cash generative cloud infrastructure provider.





This material is marketing content and should not be regarded as investment advice. Trading financial instruments carries risks and historic performance is not a guarantee of future results.

The instrument(s) referenced in this content may be issued by a partner, from whom Saxo receives promotional fees, payment or retrocessions. While Saxo may receive compensation from these partnerships, all content is created with the aim of providing clients with valuable information and options.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.